scispace - formally typeset
G

Gerald Niedobitek

Researcher at University of Erlangen-Nuremberg

Publications -  183
Citations -  12851

Gerald Niedobitek is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Epstein–Barr virus & Virus. The author has an hindex of 62, co-authored 183 publications receiving 12262 citations. Previous affiliations of Gerald Niedobitek include University of Birmingham & Free University of Berlin.

Papers
More filters
Journal ArticleDOI

Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages

TL;DR: The detection of pSTAT1, RBP-J, and CMAF in the context of CD68 or CD163 expression is a suitable tool for the characterisation of macrophage polarisation in situ, and CD163 cannot be considered a reliable M2 marker when used on its own.
Journal ArticleDOI

Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

TL;DR: In situ hybridization revealed that in two HD cases, the EBV infected cells had the distinct morphology of Hodgkin and Reed-Sternberg cells, thus suggesting a direct pathoetiological relationship between EBV and some cases of HD.
Journal ArticleDOI

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

TL;DR: The findings support the concept of a pathoetiological role of EBV in many cases of Hodgkin disease and confirm previous studies establishing the presence ofEBV genomes in Hodgkin and Reed-Sternberg cells by demonstrating expression of an EBV-encoded protein in the tumor-cell population.
Journal ArticleDOI

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.

TL;DR: Preliminary results on viral gene expression in HRS cells are extended by adopting polymerase chain reaction-based and in situ hybridization assays capable of detecting specific EBV latent transcripts diagnostic of the different possible forms of EBV latency.
Journal ArticleDOI

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

TL;DR: It is shown that all carcinomas and all non-neoplastic epithelial cells, except hepatocytes, parietal cells, and apical cell layers in squamous epithelia, homogeneously expressed Ber-EP4 antigen.